A new class of 7-deazaguanine agents targeting autoimmune diseases: dramatic reduction of synovial fibroblast IL-6 production from human rheumatoid arthritis patients and improved performance against murine experimental autoimmune encephalomyelitisRSC MEDICINAL CHEMISTRYIF3.62024-01-011OAAI
STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell FunctionFRONTIERS IN IMMUNOLOGYIF5.92019-08-2870OAAI
Joint morphogenetic cells in the adult mammalian synoviumNATURE COMMUNICATIONSIF15.72017-05-16144OAAI
Mesenchymal stem cells for the management of rheumatoid arthritis: immune modulation, repair or both?CURRENT OPINION IN RHEUMATOLOGYIF4.32017-03-0188OAAI
Evaluation of the Early In Vivo Response of a Functionally Graded Macroporous Scaffold in an Osteochondral Defect in a Rabbit ModelANNALS OF BIOMEDICAL ENGINEERINGIF5.42015-10-0515OAAI
Evaluation of Cartilage Repair by Mesenchymal Stem Cells Seeded on a PEOT/PBT Scaffold in an Osteochondral DefectANNALS OF BIOMEDICAL ENGINEERINGIF5.42015-01-1521PREAI
A chondromimetic microsphere for in situ spatially controlled chondrogenic differentiation of human mesenchymal stem cellsJOURNAL OF CONTROLLED RELEASEIF11.52014-04-0134PRE
DEVELOPMENT OF GROWTH FACTOR TETHERED HYALURONAN MICROSPHERES FOR IN SITU CHONDROGENIC DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLSOSTEOARTHRITIS AND CARTILAGEIF92014-04-010OA
STRATEGIES FOR IMPROVED TARGETING OF THERAPEUTIC CELLS: IMPLICATIONS FOR TISSUE REPAIREUROPEAN CELLS & MATERIALSIF3.12012-04-2146OA